Science Explorer Back to mapMap

Most cited papers from Nemours Children's Health System

What are the most cited papers from Nemours Children's Health System?

The most cited paper from Nemours Children's Health System is "Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children" (Alexander Edward Dela Cruz Drilon et al., 2018), with 2,827 citations. Next come "Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy" (2,357) and "Pathology of Neurodegenerative Diseases" (1,673).

Showing 50 of 60 papers. Every paper with more than 290 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Alexander Edward Dela Cruz Drilon et al. · New England Journal of Medicine Open access 21 Feb 2018 2,827
2 Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel et al. · New England Journal of Medicine Open access Nov 2017 2,357
3 Pathology of Neurodegenerative Diseases Brittany N. Dugger, Dennis W. Dickson · Cold Spring Harbor Perspectives in Biology Open access 6 Jan 2017 1,673
4 Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper Thomas Lener et al. · Journal of Extracellular Vesicles Open access 2015 1,591
5 Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy Eugenio Maria Mercuri et al. · New England Journal of Medicine Open access 14 Feb 2018 1,466
6 Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting Claus Højbjerg Gravholt, N.H. Andersen, Gerard Conway et al. · European Journal of Endocrinology Open access 13 Jul 2017 1,119
7 Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study Richard S. Finkel, Claudia A. Chiriboga, Jiri Vajsar et al. · The Lancet Dec 2016 1,043
8 Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials David S. Hong et al. · The Lancet Oncology Open access 24 Feb 2020 1,026
9 Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial Denice S. Feig et al. · The Lancet Open access128 authors 15 Sep 2017 806
10 Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B Ian D. Krantz et al. · Nature Genetics Open access 16 May 2004 729
11 American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock Alan L. Davis et al. · Critical Care Medicine Open access 17 May 2017 681
12 Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study Darryl C. De Vivo et al. · Neuromuscular Disorders Open access 12 Sep 2019 647
13 Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants Santhosh Girirajan et al. · New England Journal of Medicine Open access 12 Sep 2012 645
14 Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism Ute I. Scholl et al. · Nature Genetics Open access 4 Aug 2013 630
15 Complications of Growing-Rod Treatment for Early-Onset Scoliosis Shay Bess, Behrooz A. Akbarnia, George H. Thompson et al. · Journal of Bone and Joint Surgery Oct 2010 591
16 Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study Theodore Willis Laetsch, Steven G. DuBois, Leo Mascarenhas et al. · The Lancet Oncology Open access 29 Mar 2018 564
17 International Consensus Criteria for Pediatric Sepsis and Septic Shock Luregn Jan Schlapbach et al. · JAMA Open access 21 Jan 2024 563
18 Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3 Ana Paula Abreu et al. · New England Journal of Medicine Open access 5 Jun 2013 539
19 Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial Russell E. Ware et al. · The Lancet Open access 6 Dec 2015 524
20 Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics Priya Sunil Kishnani, Stephanie L. Austin, José E. Abdenur et al. · Genetics in Medicine Open access 30 Oct 2014 514
21 Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial John W Day et al. · The Lancet Neurology 18 Mar 2021 497
22 Comparison of Cuffed and Uncuffed Endotracheal Tubes in Young Children during General Anesthesia Henry H. Khine, David H. Corddry, Robert G. Kettrick et al. · Anesthesiology Open access Mar 1997 480
23 Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Craig M. McDonald et al. · The Lancet Open access 17 Jul 2017 463
24 Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Johannes D. Veldhuis, James N. Roemmich, Erick J Richmond et al. · Endocrine Reviews 7 Dec 2004 458
25 A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors Alexander Edward Dela Cruz Drilon et al. · Cancer Discovery Open access 3 Jun 2017 444
26 An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge Catherine A. Brownstein et al. · Genome biology Open access198 authors 25 Mar 2014 433
27 Natural history of infantile‐onset spinal muscular atrophy Stephen J. Kolb et al. · Annals of Neurology Open access 17 Nov 2017 421
28 Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization Jenelle H. Badulak et al. · ASAIO Journal Open access 26 Feb 2021 413
29 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. Fritz Horber, Morey W. Haymond · Journal of Clinical Investigation Open access Jul 1990 413
30 Differential Transport and Local Translation of Cytoskeletal, Injury-Response, and Neurodegeneration Protein mRNAs in Axons Dianna E. Willis, Ka Wan Li, Jun-Qi Zheng et al. · Journal of Neuroscience Open access 26 Jan 2005 384
31 A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections Nathan Kuppermann et al. · Archives of Pediatrics and Adolescent Medicine Open access 18 Feb 2019 380
32 Revised upper limb module for spinal muscular atrophy: Development of a new module Elena Stacy Mazzone et al. · Muscle & Nerve 12 Oct 2016 375
33 The Effectiveness of Direct Instruction Curricula: A Meta-Analysis of a Half Century of Research Jean Stockard, Timothy W. Wood, Cristy Coughlin et al. · Review of Educational Research Review 7 Jan 2018 370
34 Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity1 Nelly Mauras, Valerie Y. Hayes, Susan A. Welch et al. · The Journal of Clinical Endocrinology & Metabolism Jun 1998 370
35 Association of Antenatal Corticosteroids With Mortality and Neurodevelopmental Outcomes Among Infants Born at 22 to 25 Weeks' Gestation Waldemar A. Carlo · JAMA Open access 6 Dec 2011 366
36 A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohnʼs Disease Athos Bousvaros, Stefano Guandalini, Robert N. Baldassano et al. · Inflammatory Bowel Diseases Open access 22 Aug 2005 361
37 Systematic Review: A Reevaluation and Update of the Integrative (Trajectory) Model of Pediatric Medical Traumatic Stress Julia Price, Nancy Kassam‐Adams, Melissa A. Alderfer et al. · Journal of Pediatric Psychology Review 28 Aug 2015 355
38 CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis Vera Fridman et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 27 Nov 2014 355
39 Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation Patrick A. Flume, Theodore G. Liou, Drucy Borowitz et al. · CHEST Journal Open access 3 Mar 2012 335
40 Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience Jeffrey S. Hyams, James F. Markowitz, Anthony R. Otley et al. · Journal of Pediatric Gastroenterology and Nutrition Oct 2005 331
41 Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium M K Javaid et al. · Orphanet Journal of Rare Diseases Open access 13 Jun 2019 330
42 Forearm and Distal Radius Fractures in Children Kenneth J. Noonan, Charles T. Price · Journal of the American Academy of Orthopaedic Surgeons May 1998 330
43 Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma Diana M Sobieraj, Erin R. Weeda, Elaine Nguyen et al. · JAMA Open access 19 Mar 2018 326
44 Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population Tomomitsu Hirota et al. · Nature Genetics Open access 31 Jul 2011 325
45 NIPBL Mutational Analysis in 120 Individuals with Cornelia de Lange Syndrome and Evaluation of Genotype-Phenotype Correlations Lynette A. Gillis, Jennifer McCallum, Maninder Kaur et al. · The American Journal of Human Genetics Open access 12 Sep 2004 322
46 Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial Kevin A. Strauss, Michelle Anne Farrar, Francesco Muntoni et al. · Nature Medicine Open access 17 Jun 2022 318
47 Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy Eric B. Geller et al. · Epilepsia Open access 11 Apr 2017 318
48 Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial Michael W. Konstan, Patrick A. Flume, Matthias Kappler et al. · Journal of Cystic Fibrosis Open access 13 Nov 2010 317
49 Intense Pulsed Light Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction; A 3-Year Retrospective Study Rolando Toyos, William McGill, Dustin Briscoe · Photomedicine and Laser Surgery Open access 2015 316
50 Appraisal of the pediatric ulcerative colitis activity index (PUCAI) Dan Turner, Jeffrey S. Hyams, James F. Markowitz et al. · Inflammatory Bowel Diseases 22 Jan 2009 313

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.